145 related articles for article (PubMed ID: 36211389)
1. Basiliximab for the therapy of acute T cell-mediated rejection in kidney transplant recipient with BK virus infection: A case report.
Chen T; Li X; Wang J; Wang X; Zhu T; Rong R; Yang C
Front Immunol; 2022; 13():1017872. PubMed ID: 36211389
[TBL] [Abstract][Full Text] [Related]
2. BK polyomavirus nephropathy complicated with acute T-cell-mediated rejection in a kidney transplant recipient: a case report.
Tanabe T; Shimizu T; Sai K; Miyauchi Y; Shirakawa H; Ishida H; Honda K; Koike J; Yamaguchi Y; Tanabe K
Clin Transplant; 2011 Jul; 25 Suppl 23():39-43. PubMed ID: 21623913
[TBL] [Abstract][Full Text] [Related]
3. [Oscillation between BK virus nephropathy and rejection--the frustrating course of a living donor transplantation].
Materne C; Gerth J; Ott U; Gröne HJ; Wolf G
Med Klin (Munich); 2009 Aug; 104(8):644-8. PubMed ID: 19701735
[TBL] [Abstract][Full Text] [Related]
4. Factors and outcome in BK virus nephropathy in a Hispanic kidney transplant population.
Pérez-Torres D; Bertrán-Pasarell J; Santiago-Delpín E; González-Ramos M; Medina-Mangual S; Morales-Otero L; González-Caraballo Z
Transpl Infect Dis; 2010 Feb; 12(1):16-22. PubMed ID: 19804584
[TBL] [Abstract][Full Text] [Related]
5. BIOPSY-PROVEN BK VIRUS NEPHROPATHY WITHOUT DETECTABLE BK VIREMIA IN A ONE-YEAR POST-KIDNEY TRANSPLANT RECIPIENT.
Ruangkanchanasetr P; Pumchandh N; Satirapoj B; Termmathurapoj S; Pongthanapisith V
Southeast Asian J Trop Med Public Health; 2015 Jul; 46(4):657-61. PubMed ID: 26867385
[TBL] [Abstract][Full Text] [Related]
6. Successful Management of Combined BK Nephropathy and Nocardiosis in a Renal Transplant Recipient: Case Report.
Abdeltawab K; Denewar A; Gheith O; Zein Eldin S; Yagen J; AbdelMonem M; Elsayed Z; Nair P; Altailji S; Al-Otaibi T
Exp Clin Transplant; 2022 Mar; 20(Suppl 1):140-144. PubMed ID: 35384825
[TBL] [Abstract][Full Text] [Related]
7. Early monitoring of the human polyomavirus BK replication and sequencing analysis in a cohort of adult kidney transplant patients treated with basiliximab.
Anzivino E; Bellizzi A; Mitterhofer AP; Tinti F; Barile M; Colosimo MT; Fioriti D; Mischitelli M; Chiarini F; Ferretti G; Taliani G; Pietropaolo V
Virol J; 2011 Aug; 8():407. PubMed ID: 21849069
[TBL] [Abstract][Full Text] [Related]
8. Successful rescue of late-onset acute T-cell mediated rejection with anti-CD25 antibody: a case report.
Osawa T; Harada H; Miura M; Ogawa Y; Morooka K; Nakamura M; Tanabe T; Takada N; Seki T; Togashi M; Takenouchi T; Hirano T
Clin Transplant; 2009 Aug; 23 Suppl 20():31-3. PubMed ID: 19594593
[TBL] [Abstract][Full Text] [Related]
9. Association of treatment with 15-deoxyspergualin and BK virus nephropathy in kidney allograft recipients.
Shi Y; Moriyama T; Namba Y; Yamanaka M; Hanafuse T; Imamura R; Ichimaru N; Oka K; Kyo M; Tian Y; Takahara S; Ichikawa S; Okuyama A
Clin Transplant; 2007; 21(4):502-9. PubMed ID: 17645710
[TBL] [Abstract][Full Text] [Related]
10. In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.
Mohamed M; Parajuli S; Muth B; Astor BC; Panzer SE; Mandelbrot D; Zhong W; Djamali A
Transpl Infect Dis; 2016 Jun; 18(3):361-71. PubMed ID: 26998753
[TBL] [Abstract][Full Text] [Related]
11. Reversible Ischemic Nephropathy in a Deceased Donor Renal Transplant Recipient With BK Nephropathy.
Gheith O; Al-Otaibi T; Elserwy N; Elsawy I; Donia F; Fathi T; Goerge S; Eid HS; Nair P
Exp Clin Transplant; 2022 Mar; 20(Suppl 1):132-135. PubMed ID: 35384823
[TBL] [Abstract][Full Text] [Related]
12. Urinary cell mRNA profiling of kidney allograft recipients: Development of a portable protocol for noninvasive diagnosis of T cell mediated rejection and BK virus nephropathy.
Salinas T; Li C; Snopkowski C; Stryjniak G; Shankaranarayanan D; Albakry S; Ding R; Sharma VK; Salvatore SP; Seshan SV; Dadhania DM; Muthukumar T; Suthanthiran M
J Immunol Methods; 2023 Jan; 512():113402. PubMed ID: 36493873
[TBL] [Abstract][Full Text] [Related]
13. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
14. High-Dose Intravenous Immunoglobulin Treatment of Polyomavirus Nephropathy Developing After T Cell-Mediated Rejection Treatment: A Case Report.
Hwang SD; Lee JH; Lee SW; Kim JK; Kim MJ; Song JH
Transplant Proc; 2018 Oct; 50(8):2575-2578. PubMed ID: 29871774
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic and therapeutic dilemma of the co-existence of BK virus nephropathy with acute rejection - an experience from a single Centre and review of the literature.
Shanmugham S; Bhadauria D; Agrawal V; Jain M; Yaccha M; Kaul A; Vamsidhar V; Meyyappan J; Prasad N
Transpl Immunol; 2022 Jun; 72():101581. PubMed ID: 35301106
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy.
Saad ER; Bresnahan BA; Cohen EP; Lu N; Orentas RJ; Vasudev B; Hariharan S
Transplantation; 2008 Mar; 85(6):850-4. PubMed ID: 18360267
[TBL] [Abstract][Full Text] [Related]
17. Nephritic-nephrotic syndrome as a presentation of BK virus infection.
Derakhshan N; Derakhshan D; Torabinejad S; Derakhshan A
Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):123-5. PubMed ID: 21196627
[TBL] [Abstract][Full Text] [Related]
18. Active management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant.
Halim MA; Al-Otaibi T; Gheith O; Zkaria Z; Mosaad A; Said T; Nair P; Nampoory N
Exp Clin Transplant; 2014 Dec; 12(6):528-33. PubMed ID: 25489803
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil in pediatric renal transplantation: non-induction vs. induction with basiliximab.
Ojogho O; Sahney S; Cutler D; Baron PW; Abdelhalim FM; James S; Zuppan C; Franco E; Concepcion W
Pediatr Transplant; 2005 Feb; 9(1):80-3. PubMed ID: 15667617
[TBL] [Abstract][Full Text] [Related]
20. Temporal serum creatinine increase and exacerbation of tubulointerstitial inflammation during the first two months in resolving polyomavirus BK nephropathy.
Masutani K; Tsuchimoto A; Matsukuma Y; Kurihara K; Nishiki T; Kitada H; Tanaka M; Kitazono T; Tsuruya K
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():45-50. PubMed ID: 26031586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
